Stephen T Worland's Net Worth
$7.42 Million
Who is Stephen T Worland?
Stephen T Worland has an estimated net worth of $7.42 Million. This is based on reported shares across multiple companies, which include GenMark Diagnostics, Inc., eFFECTOR Therapeutics, Inc., Tracon Pharmaceuticals, Inc., and ANADYS PHARMACEUTICALS INC.
SEC CIK
Stephen T Worland's CIK is 0001283307
Past Insider Trading and Trends
2007 was Stephen T Worland's most active year for acquiring shares with 13 total transactions. Stephen T Worland's most active month to acquire stocks was the month of July. 2006 was Stephen T Worland's most active year for disposing of shares, totalling 3 transactions. Stephen T Worland's most active month to dispose stocks was the month of February. 2021 saw Stephen T Worland paying a total of $500,000.00 for 2,366,760 shares, this is the most they've acquired in one year. In 2006 Stephen T Worland cashed out on 10,000 shares for a total of $148,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
GenMark Diagnostics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +38.04% | 5.68K |
—
|
—
| 20.6K |
May 29
| |||
Form 4
|
∞
| 14.92K |
—
|
—
| 14.92K |
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
eFFECTOR Therapeutics, Inc. (EFTR) Snapshot price: $10.19
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 4
| +2.29% | 5.98K |
$0.50 | $2,973.36 | 267.2K |
Nov 15
| |||
Form 4
| +14.86% | 33.8K |
$0.52 | $17,575.48 | 261.23K |
Aug 11
| |||
Form 4
| +2.90% | 6.4K |
$0.46 | $2,938.06 | 227.43K |
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
| +2.81% | 6.05K |
$0.47 | $2,832.41 | 221.03K |
Nov 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
| +10.26% | 20K |
$1.37 | $27,400.00 | 214.98K |
Jun 7
| |||
Form 4
| +0.95% | 1.84K |
$1.53 | $2,810.61 | 194.98K |
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 20
| |||
Form 4
| +134.35% | 755.48K |
$10.00 |
—
| 1.32M |
Aug 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Tracon Pharmaceuticals, Inc. (TCON) Snapshot price: $0.19
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
∞
| 7.5K |
—
|
—
| 7.5K |
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ANADYS PHARMACEUTICALS INC No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 10
| |||
Form 4
| +88.23% | 33.9K |
$2.95 | $99,999.10 | 72.32K |
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 6
| |||
Form 4
| +255.52% | 150K |
$2.04 | $305,937.84 | 208.7K |
Aug 30 - Sep 4
| |||
Form 4/A
| +702.84% | 25K |
$2.95 | $73,750.00 | 28.56K |
Jan 12
| |||
Form 4
| +966.74% | 25K |
$2.95 | $73,750.00 | 27.59K |
Jan 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 8
| |||
Form 4
| -6.38% | -4.00K |
$16.00 | -$64,000.00 | 58.7K |
Scheduled
|
Mar 16
| ||
Form 4/A
| -4.57% | -3.00K |
$14.00 | -$42,000.00 | 62.7K |
Scheduled
|
Mar 2
| ||
Form 4
| -4.54% | -3.00K |
$14.00 | -$42,000.00 | 63.08K |
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4
| +2,668.07% | 25.4K |
$2.95 | $74,930.00 | 26.35K |
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||